Joint Meeting of Conjoint Committee on CE and FDA Focuses on REMS

August 28, 2015
Posted by: 
Tamar Hosansky

Meeting Describes Value of CE in Supporting FDA REMS

Kate Regnier, MA, MBA, Executive Vice President, ACCME, attended the joint meeting of the Conjoint Committee on Continuing Education (CCCE) and the Food and Drug Administration (FDA), held in July in Silver Spring, Maryland. Ms. Regnier moderated a panel discussion for CE accreditors, with representatives from the Accreditation Council for Pharmacy Education (ACPE), the American Nurses Credentialing Center (ANCC), and the American Academy of Physician Assistants (AAPA). The colleague accreditors focused on the value of CE in supporting the Extended-Release and Long-Acting Opioid Analgesic REMS, presented data on the scope of REMS-compliant continuing education activities, and discussed the responsibility of accreditors in the REMS process.